Miguel Debono, Mike Bradburn, Matthew Bull, Barney Harrison, Richard J. Ross, John Newell-Price. Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. J Clin Endocrinol Metab. 2014;99(12):4462-4470.
Adrenocortical adenomas, also known as adrenal adenomas, are found on approximately 4.5% of all computed tomography scans. On routine clinical testing, many patients exhibit biochemical evidence of excess cortisol secretion, but without the associated features of classically described overt Cushing syndrome.* This is referred to as hypercortisolism without Cushingoid features, or less severe hypercortisolism.† Previous studies have linked classically described overt Cushing syndrome to an increase in cardiovascular events and mortality. Other studies have determined that even less severe forms of hypercortisolism can lead to insulin resistance, hypertension, and visceral obesity. Therefore, it is essential to understand the significance of cortisol management in these patients. This study hypothesized that patients with adrenal adenomas and hypercortisolism may have an increased risk of cardiovascular events and mortality, even without exhibiting the phenotypic features associated with classically described overt Cushing syndrome. Moreover, the study explored how higher or lower levels of cortisol secretion affect mortality rates in these patients.
To explore this, the mortality rates of patients with adrenal adenomas and various levels of cortisol secretion were studied over an 8-year retrospective analysis. At the baseline of the study, patient cortisol levels were assessed using the overnight dexamethasone suppression test (DST), which detects autonomous cortisol secretion in the blood. The study then compared this data with the published mortality rates locally in Sheffield and nationally across the United Kingdom. Study results demonstrated a link between cortisol levels and mortality rate, concluding that patients with hypercortisolism (post-DST >1.8 μg/dL) have greater mortality. Additionally, study findings revealed a higher rate of mortality from circulatory and respiratory infection causes for patients with adrenal adenomas and evidence of hypercortisolism based on the DST.*Biochemical evidence = lab results.
Survival by Post-DST Cortisol Levels*
The study found that patients with adrenal adenomas and post-DST >1.8 μg/dL had an increased mortality rate, mainly related to cardiovascular disease and infection.
Causes of Mortality in Patients With Adrenal Adenomas Compared With National Average
The most common causes of death among the patient group were atherosclerotic cardiovascular disease and respiratory diseases, mainly pneumonia.